Literature DB >> 11717599

The contribution of "mechanical" problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions.

M T Castagna1, G S Mintz, B O Leiboff, J M Ahmed, R Mehran, L F Satler, K M Kent, A D Pichard, N J Weissman.   

Abstract

OBJECTIVES: Serial intravascular ultrasonographic (IVUS) studies have shown that in-stent restenosis is the result of intimal hyperplasia (IH). However, routine preintervention IVUS imaging has suggested that many restenotic stents were inadequately deployed. The purpose of this IVUS study was to determine the incidence of mechanical problems contributing to in-stent restenosis (ISR).
METHODS: Between April 1994 and June 2000, 1090 patients with ISR were treated at the Washington Hospital Center. All underwent preintervention IVUS imaging. IVUS measurements included proximal and distal reference lumen areas and diameters; stent, minimum lumen, and IH (stent minus lumen) areas; and IH burden (IH/stent area).
RESULTS: In 49 ISR lesions (4.5%), there were morphologic findings that contributed to the restenosis. These were termed mechanical complications. Examples include (1) missing the lesion (eg, an aorto-ostial stenosis), (2) stent "crush," and (3) having the stent stripped off the balloon during the implantation procedure. Excluding mechanical complications, stent underexpansion was common. In 20% of the ISR cases the stents had a cross-sectional area (CSA) at the site of the lesion <80% of the average reference lumen area. Twenty percent of lesions had a minimum stent area <5.0 mm(2) and an additional 18% had a minimum stent area of 5.0 to 6.0 mm(2). Twenty-four percent of lesions had an IH burden <60%.
CONCLUSION: Mechanical problems related to stent deployment procedures contribute to a significant minority of ISR lesions (approximately 25%).

Entities:  

Mesh:

Year:  2001        PMID: 11717599     DOI: 10.1067/mhj.2001.119613

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?

Authors:  Shoichi Kuramitsu; Shinichi Shirai; Kenji Ando
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Incidence of stent under-deployment as a cause of in-stent restenosis in long stents.

Authors:  Olivier F Bertrand; Robert De Larochellière; Michel Joyal; Raoul Bonan; Rosaire Mongrain; Jean-Claude Tardif
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

3.  Incidence of stent under-deployment as a cause of in-stent restenosis in long stents: take your lesson!

Authors:  William Wijns
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

4.  Repeated beta irradiation for failed intracoronary radiation therapy in patients with in-stent restenosis.

Authors:  E Eeckhout; C Roguelov; A Berger; X Lyon; C Imsand; G Girod; P Coucke
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  New imaging techniques for diagnosing coronary artery disease.

Authors:  Esteban Escolar; Guy Weigold; Anthon Fuisz; Neil J Weissman
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

6.  Impact of Intravascular Ultrasound in Clinical Practice.

Authors:  Andres Vasquez; Neville Mistry; Jasvindar Singh
Journal:  Interv Cardiol       Date:  2014-08

7.  Flash Ostial Balloon in Right Internal Mammary Artery Percutaneous Coronary Intervention: A Novel Approach.

Authors:  Rupak Desai; Gautam Kumar
Journal:  Cureus       Date:  2017-08-02

8.  Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.

Authors:  Zhi-Hai Yu; Hai-Tao Wang; Can Tu
Journal:  Eur J Med Res       Date:  2017-01-05       Impact factor: 2.175

9.  Compound ex vivo and in silico method for hemodynamic analysis of stented arteries.

Authors:  Farhad Rikhtegar; Fernando Pacheco; Christophe Wyss; Kathryn S Stok; Heng Ge; Ryan J Choo; Aldo Ferrari; Dimos Poulikakos; Ralph Müller; Vartan Kurtcuoglu
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.